-+ 0.00%
-+ 0.00%
-+ 0.00%

hVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets

Barchart·08/27/2026 01:00:00
Listen to the news

London, UK – 27 August 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announces the acquisition of CRS Clinical Research Services Berlin GmbH ("CRS Berlin").

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.